Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian Ingvar

Showing results (91-100 of 141) with videos related to

Pageof 15
Sort By:
Scientific Reports|March 12, 2021
Apelin promotes blood and lymph vessel formation and the growth of melanoma lung metastasisJudit Berta, Szilvia Török, Júlia Tárnoki-Zách, et al.
Nature Communications|April 9, 2024
Molecular patterns of resistance to immune checkpoint blockade in melanomaMartin Lauss, Bengt Phung, Troels Holz Borch, et al.
Proteomics|July 22, 2014
A new look at drugs targeting malignant melanoma--an application for mass spectrometry imagingYutaka Sugihara, Akos Végvári, Charlotte Welinder, et al.
Plos One|April 16, 2015
A protein deep sequencing evaluation of metastatic melanoma tissuesCharlotte Welinder, Krzysztof Pawłowski, Yutaka Sugihara, et al.
The Lancet. Oncology|October 30, 2025
Physical examinations and whole-body imaging versus physical examinations alone during follow-up after radical surgery of stage IIB-C and III cutaneous malignant melanoma (TRIM): an interim analysis of a multicentre, randomised, phase 3 trial in SwedenCecilia O Ladjevardi, Ylva Naeser, Ulf Dyrke, et al.
The Journal of Pathology|January 9, 2014
Molecular and genetic diversity in the metastatic process of melanomaKatja Harbst, Martin Lauss, Helena Cirenajwis, et al.
Scientific Reports|May 27, 2021
PTENP1-AS contributes to BRAF inhibitor resistance and is associated with adverse clinical outcome in stage III melanomaLinda Vidarsdottir, Alireza Azimi, Ishani Das, et al.
JCI Insight|August 30, 2022
DNA promoter hypermethylation of melanocyte lineage genes determines melanoma phenotypeAdriana Sanna, Bengt Phung, Shamik Mitra, et al.
European Journal of Cancer (Oxford, England : 1990)|June 26, 2012
Perceptions of genetic research and testing among members of families with an increased risk of malignant melanomaRichard Bränström, Nadine A Kasparian, Paul Affleck, et al.
JAMA Surgery|January 10, 2024
Population-Based Validation of the MIA and MSKCC Tools for Predicting Sentinel Lymph Node StatusRoger Olofsson Bagge, Rasmus Mikiver, Michael A Marchetti, et al.
Pageof 15

Showing results (91-100 of 141) with videos related to

Sort By:
Pageof 15
Scientific Reports|March 12, 2021
Apelin promotes blood and lymph vessel formation and the growth of melanoma lung metastasisJudit Berta, Szilvia Török, Júlia Tárnoki-Zách, et al.
Nature Communications|April 9, 2024
Molecular patterns of resistance to immune checkpoint blockade in melanomaMartin Lauss, Bengt Phung, Troels Holz Borch, et al.
Proteomics|July 22, 2014
A new look at drugs targeting malignant melanoma--an application for mass spectrometry imagingYutaka Sugihara, Akos Végvári, Charlotte Welinder, et al.
Plos One|April 16, 2015
A protein deep sequencing evaluation of metastatic melanoma tissuesCharlotte Welinder, Krzysztof Pawłowski, Yutaka Sugihara, et al.
The Lancet. Oncology|October 30, 2025
Physical examinations and whole-body imaging versus physical examinations alone during follow-up after radical surgery of stage IIB-C and III cutaneous malignant melanoma (TRIM): an interim analysis of a multicentre, randomised, phase 3 trial in SwedenCecilia O Ladjevardi, Ylva Naeser, Ulf Dyrke, et al.
The Journal of Pathology|January 9, 2014
Molecular and genetic diversity in the metastatic process of melanomaKatja Harbst, Martin Lauss, Helena Cirenajwis, et al.
Scientific Reports|May 27, 2021
PTENP1-AS contributes to BRAF inhibitor resistance and is associated with adverse clinical outcome in stage III melanomaLinda Vidarsdottir, Alireza Azimi, Ishani Das, et al.
JCI Insight|August 30, 2022
DNA promoter hypermethylation of melanocyte lineage genes determines melanoma phenotypeAdriana Sanna, Bengt Phung, Shamik Mitra, et al.
European Journal of Cancer (Oxford, England : 1990)|June 26, 2012
Perceptions of genetic research and testing among members of families with an increased risk of malignant melanomaRichard Bränström, Nadine A Kasparian, Paul Affleck, et al.
JAMA Surgery|January 10, 2024
Population-Based Validation of the MIA and MSKCC Tools for Predicting Sentinel Lymph Node StatusRoger Olofsson Bagge, Rasmus Mikiver, Michael A Marchetti, et al.
Pageof 15